HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build

HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

## : ActCabergoline - XML Representation

Draft as of 2026-05-21

Raw xml | Download

    <ActivityDefinition xmlns="http://hl7.org/fhir">
      <id value="ActCabergoline"/>
      <meta>
        <profile
                 value="http://hl7.org.nz/fhir/StructureDefinition/CcaActivityDefinition"/>
      </meta>
      <text>
        <status value="additional"/>
        <div xmlns="http://www.w3.org/1999/xhtml">Cabergoline administration, 2mg over 20 minutes</div>
      </text>
      <extension url="http://hl7.org.nz/fhir/StructureDefinition/sact-off-label">
        <valueBoolean value="true"/>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-location-medication-collection">
        <valueCodeableConcept>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="284748001"/>
            <display value="Pharmacy shop"/>
          </coding>
          <text value="Collect medication from Pharmacy shop"/>
        </valueCodeableConcept>
      </extension>
      <extension
                 url="http://hl7.org.nz/fhir/StructureDefinition/sact-administration-site">
        <valueCodeableConcept>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="264362003"/>
            <display value="Home"/>
          </coding>
          <text value="Administration takes place at the patients home"/>
        </valueCodeableConcept>
      </extension>
      <url
           value="http://hl7.org.nz/fhir/ig/cca/ActivityDefinition/ActCabergoline"/>
      <version value="0.1.0"/>
      <status value="draft"/>
      <date value="2026-05-21T02:29:02+00:00"/>
      <publisher value="Te Aho o Te Kahu, Cancer Control Agency"/>
      <productCodeableConcept>
        <coding>
          <system value="https://nzulm.org.nz/nzmt"/>
          <code value="10250021000116102"/>
          <display value="Cabergoline"/>
        </coding>
      </productCodeableConcept>
      <dosage>
        <text value="2 mg over 20 minutes by IV infusion"/>
        <timing>
          <code>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="123445"/>
              <display value="QID"/>
            </coding>
          </code>
        </timing>
        <route>
          <coding>
            <system value="http://snomed.info/sct"/>
            <code value="180177004"/>
            <display value="Continuous infusion of therapeutic substance"/>
          </coding>
        </route>
        <doseAndRate>
          <doseQuantity>
            <value value="2"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="mg"/>
          </doseQuantity>
          <rateQuantity>
            <value value="20"/>
            <system value="http://unitsofmeasure.org"/>
            <code value="min"/>
          </rateQuantity>
        </doseAndRate>
      </dosage>
    </ActivityDefinition>